Use of Novel Antimicrobial Agents: Evidence in Treating Pediatric and Neonatal Patients

Posted on May 23, 2023
Dr. Heger

Speaker:
Margaret Heger, PharmD, BCPS, BCPPS
Pediatric Pharmacy Supervisor
PGY2 Pediatric Pharmacy Residency Program Director
OSF HealthCare Children’s Hospital of Illinois

 

A Knowledge-Based Activity
ACPE UAN # 0016-0000-23-036-L01-P, 1.0 contact hour, 1.0 AMA PRA Category 1 Credit(s)™ CME, 1.0 contact hour CNE

Learning Objectives:

  • Describe the evidence supporting novel antimicrobials in treating resistant gram negative infections and dosing in pediatric and neonatal patients.
  • Describe the evidence supporting novel antimicrobials in treating resistant gram positive infections and dosing in pediatric and neonatal patients.
  • Review evidence supporting shorter course antibiotics for pediatric pneumonia.

Speaker Disclosures

All other speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose.

Modified on August 14, 2023